Market Cap 5.09B
Revenue (ttm) 953.68M
Net Income (ttm) 128.48M
EPS (ttm) N/A
PE Ratio 32.06
Forward PE 30.31
Profit Margin 13.47%
Debt to Equity Ratio 0.14
Volume 147,300
Avg Vol 168,948
Day's Range N/A - N/A
Shares Out 32.39M
Stochastic %K 81%
Beta 0.94
Analysts Sell
Price Target $205.00

Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified...

Industry: Specialty Chemicals
Sector: Basic Materials
Phone: 845 326 5600
Address:
5 Paragon Drive, Montvale, United States
PrivateProfiteer
PrivateProfiteer Nov. 14 at 4:36 AM
$BCPC is currently trading at $156.99, showing a neutral RSI of 51.19, indicating a lack of strong momentum in either direction. The stock is above its 30-day moving average (MA30) of 150.52 and its 50-day moving average (MA50) of 151.89, suggesting a bullish trend in the short to medium term. The recent 60-day high of 166.47 provides a key resistance level, while the 60-day low of 139.17 offers support. Directional bias leans bullish due to the price being above the MAs and the RSI indicating room for upward movement. Suggested entry point is around $157.50, just above the last close to capture potential upward momentum. Set a stop loss at $153.00 to manage risk. Target 1 is $165.00, near the recent high, and Target 2 is $168.00, allowing for a breakout scenario. Monitor market conditions closely, as volatility (ATR of 3.03) could impact price movements. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 2:42 AM
$BCPC: The last close at $156.11 indicates a position above the 30-day moving average (MA30) of $149.81 and near the 50-day moving average (MA50) of $152.04, suggesting a bullish context. The RSI of 46.21 indicates that the stock is neither overbought nor oversold, providing room for upward movement. The 60-day high of $166.47 offers a potential resistance level, while the low of $139.17 establishes a support range. Directional bias is cautiously bullish, as the stock is trading above the MA30 and MA50, but the RSI suggests a need for confirmation before a strong move. Suggested entry: $157.00 (above the last close). Stop: $153.00 (below the MA50). Targets: $165.00 (near the 60D high) and $170.00 (psychological level). Monitor for any changes in market conditions or volatility. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 2:18 AM
$BCPC: The last close at $156.11 indicates a position above the 30-day moving average (MA30) of $149.81 and near the 50-day moving average (MA50) of $152.04, suggesting a bullish context. The RSI of 46.21 indicates that the stock is neither overbought nor oversold, providing room for upward movement. The 60-day high of $166.47 offers a potential resistance level, while the low of $139.17 establishes a support range. Directional bias is cautiously bullish, as the stock is trading above the MA30 and MA50, but the RSI suggests a need for confirmation before a strong move. Suggested entry: $157.00 (above the last close). Stop: $153.00 (below the MA50). Targets: $165.00 (near the 60D high) and $170.00 (psychological level). Monitor for any changes in market conditions or volatility. https://privateprofiteers.com
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 7 at 4:55 PM
0 · Reply
NVDAMillionaire
NVDAMillionaire Oct. 27 at 3:45 PM
$BCPC Really good write-up that perfectly summarizes BCPC's present situation. So if you want to bring your BCPC knowledge up to date or just discover BCPC, this is required reading. https://beyondspx.com/quote/BCPC/analysis/balchem-s-precision-growth-leveraging-niche-innovation-for-sustained-market-leadership-nasdaq-bcpc
0 · Reply
JarvisFlow
JarvisFlow Oct. 22 at 11:53 AM
HC Wainwright & Co. updates rating for Balchem ( $BCPC ) to Buy, target set at 189 → 190.
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Oct. 21 at 11:02 AM
$BCPC Balchem Q3 Adj. EPS $1.35 Beats $1.31 Estimate, Sales $267.558M Beat $258.282M Estimate
0 · Reply
AlgoTwitch
AlgoTwitch Sep. 15 at 6:54 AM
$BCPC Outlook tied to macro sensitivity and commodity/input costs
0 · Reply
CyberSecurityBets
CyberSecurityBets Aug. 23 at 7:08 AM
$BCPC Balchem Corporation is a specialty chemicals company with stable end markets but premium valuation
0 · Reply
RunnerSignals
RunnerSignals Aug. 23 at 5:53 AM
$BCPC $CFR $CNQ $CRL $EFX all pushed above their 200DMA today. Some steady, some gaining steam worth watching if momentum holds https://stocksrunner.com/news/2025-08-22-advanced-technical-analysis-for-stock-trading-strategies
0 · Reply
Latest News on BCPC
Balchem Corporation (BCPC) Q3 2025 Earnings Call Transcript

Oct 21, 2025, 1:54 PM EDT - 23 days ago

Balchem Corporation (BCPC) Q3 2025 Earnings Call Transcript


Balchem Corporation (BCPC) Q2 2025 Earnings Call Transcript

Aug 1, 2025, 4:27 AM EDT - 3 months ago

Balchem Corporation (BCPC) Q2 2025 Earnings Call Transcript


Balchem Corporation (BCPC) Q1 2025 Earnings Call Transcript

Apr 24, 2025, 6:52 PM EDT - 7 months ago

Balchem Corporation (BCPC) Q1 2025 Earnings Call Transcript


Balchem Corporation Announces Dividend

Dec 10, 2024, 4:10 PM EST - 1 year ago

Balchem Corporation Announces Dividend


Balchem's Q3 Shows Record Earnings And Valuation Pressure

Oct 28, 2024, 10:00 AM EDT - 1 year ago

Balchem's Q3 Shows Record Earnings And Valuation Pressure


Balchem Corporation (BCPC) Q3 2024 Earnings Call Transcript

Oct 25, 2024, 5:30 PM EDT - 1 year ago

Balchem Corporation (BCPC) Q3 2024 Earnings Call Transcript


Balchem Corporation (BCPC) Q2 2024 Earnings Call Transcript

Jul 26, 2024, 4:46 PM EDT - 1 year ago

Balchem Corporation (BCPC) Q2 2024 Earnings Call Transcript


Top 2 Materials Stocks You May Want To Dump This Month

Jul 9, 2024, 8:00 AM EDT - 1 year ago

Top 2 Materials Stocks You May Want To Dump This Month

AU


Balchem Corporation (BCPC) Q1 2024 Earnings Call Transcript

May 3, 2024, 3:24 PM EDT - 1 year ago

Balchem Corporation (BCPC) Q1 2024 Earnings Call Transcript


Balchem Corporation Releases 2023 Sustainability Report

Apr 22, 2024, 7:00 AM EDT - 1 year ago

Balchem Corporation Releases 2023 Sustainability Report


Balchem Corporation (BCPC) Q4 2023 Earnings Call Transcript

Feb 16, 2024, 3:08 PM EST - 1 year ago

Balchem Corporation (BCPC) Q4 2023 Earnings Call Transcript


Balchem Q3: A Solid Performer Is Seeing A Soft 2023

Oct 27, 2023, 4:56 PM EDT - 2 years ago

Balchem Q3: A Solid Performer Is Seeing A Soft 2023


Balchem Corporation (BCPC) Q3 2023 Earnings Call Transcript

Oct 27, 2023, 2:32 PM EDT - 2 years ago

Balchem Corporation (BCPC) Q3 2023 Earnings Call Transcript


PrivateProfiteer
PrivateProfiteer Nov. 14 at 4:36 AM
$BCPC is currently trading at $156.99, showing a neutral RSI of 51.19, indicating a lack of strong momentum in either direction. The stock is above its 30-day moving average (MA30) of 150.52 and its 50-day moving average (MA50) of 151.89, suggesting a bullish trend in the short to medium term. The recent 60-day high of 166.47 provides a key resistance level, while the 60-day low of 139.17 offers support. Directional bias leans bullish due to the price being above the MAs and the RSI indicating room for upward movement. Suggested entry point is around $157.50, just above the last close to capture potential upward momentum. Set a stop loss at $153.00 to manage risk. Target 1 is $165.00, near the recent high, and Target 2 is $168.00, allowing for a breakout scenario. Monitor market conditions closely, as volatility (ATR of 3.03) could impact price movements. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 2:42 AM
$BCPC: The last close at $156.11 indicates a position above the 30-day moving average (MA30) of $149.81 and near the 50-day moving average (MA50) of $152.04, suggesting a bullish context. The RSI of 46.21 indicates that the stock is neither overbought nor oversold, providing room for upward movement. The 60-day high of $166.47 offers a potential resistance level, while the low of $139.17 establishes a support range. Directional bias is cautiously bullish, as the stock is trading above the MA30 and MA50, but the RSI suggests a need for confirmation before a strong move. Suggested entry: $157.00 (above the last close). Stop: $153.00 (below the MA50). Targets: $165.00 (near the 60D high) and $170.00 (psychological level). Monitor for any changes in market conditions or volatility. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 2:18 AM
$BCPC: The last close at $156.11 indicates a position above the 30-day moving average (MA30) of $149.81 and near the 50-day moving average (MA50) of $152.04, suggesting a bullish context. The RSI of 46.21 indicates that the stock is neither overbought nor oversold, providing room for upward movement. The 60-day high of $166.47 offers a potential resistance level, while the low of $139.17 establishes a support range. Directional bias is cautiously bullish, as the stock is trading above the MA30 and MA50, but the RSI suggests a need for confirmation before a strong move. Suggested entry: $157.00 (above the last close). Stop: $153.00 (below the MA50). Targets: $165.00 (near the 60D high) and $170.00 (psychological level). Monitor for any changes in market conditions or volatility. https://privateprofiteers.com
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 7 at 4:55 PM
0 · Reply
NVDAMillionaire
NVDAMillionaire Oct. 27 at 3:45 PM
$BCPC Really good write-up that perfectly summarizes BCPC's present situation. So if you want to bring your BCPC knowledge up to date or just discover BCPC, this is required reading. https://beyondspx.com/quote/BCPC/analysis/balchem-s-precision-growth-leveraging-niche-innovation-for-sustained-market-leadership-nasdaq-bcpc
0 · Reply
JarvisFlow
JarvisFlow Oct. 22 at 11:53 AM
HC Wainwright & Co. updates rating for Balchem ( $BCPC ) to Buy, target set at 189 → 190.
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Oct. 21 at 11:02 AM
$BCPC Balchem Q3 Adj. EPS $1.35 Beats $1.31 Estimate, Sales $267.558M Beat $258.282M Estimate
0 · Reply
AlgoTwitch
AlgoTwitch Sep. 15 at 6:54 AM
$BCPC Outlook tied to macro sensitivity and commodity/input costs
0 · Reply
CyberSecurityBets
CyberSecurityBets Aug. 23 at 7:08 AM
$BCPC Balchem Corporation is a specialty chemicals company with stable end markets but premium valuation
0 · Reply
RunnerSignals
RunnerSignals Aug. 23 at 5:53 AM
$BCPC $CFR $CNQ $CRL $EFX all pushed above their 200DMA today. Some steady, some gaining steam worth watching if momentum holds https://stocksrunner.com/news/2025-08-22-advanced-technical-analysis-for-stock-trading-strategies
0 · Reply
JarvisFlow
JarvisFlow Aug. 4 at 1:00 PM
HC Wainwright & Co. updates rating for Balchem ( $BCPC ) to Buy, target set at 180 → 189.
0 · Reply
CatCapital_ai
CatCapital_ai Jul. 31 at 11:21 AM
$BCPC Earnings - Q2/2025 Revenue: $255.5M ✅ vs. $250.31M est. EPS: $1.17 ✅ vs. $1.12 est. Balchem hits record Q2 sales and EBITDA driven by strong growth across all segments. Company plans a $36M micro-encapsulation facility and benefits from EU anti-dumping duties on Chinese choline chloride. Long-term outlook remains confident amid solid financial performance.
0 · Reply
CatCapital_ai
CatCapital_ai Jul. 31 at 11:15 AM
$BCPC Earnings - Q2/2025 Revenue: $255.5M ✅ vs. $250.31M est. EPS: $1.17 ✅ vs. $1.12 est. Balchem hits record Q2 with strong growth across all segments! Outlook remains positive with continued innovation and market expansion. Company confident in long-term growth trajectory.
0 · Reply
Estimize
Estimize Jun. 26 at 10:03 PM
Wall St is expecting 1.12 EPS for $BCPC Q2 [Reporting 07/25 BMO] http://www.estimize.com/intro/bcpc?chart=historical&metric_name=eps&utm_co
0 · Reply
JarvisFlow
JarvisFlow Apr. 28 at 5:47 PM
HC Wainwright & Co. updates rating for Balchem ( $BCPC ) to Buy, target set at 190 → 180.
0 · Reply
Sidoti
Sidoti Apr. 28 at 2:02 PM
New research today on $BCPC #sidotiresearch Read Note: https://buff.ly/VAaSxTZ #investing #smallcap #microcap
0 · Reply
Estimize
Estimize Apr. 24 at 10:03 AM
$BCPC reported - EPS and - revenue for Q1. http://www.estimize.com/intro/bcpc?chart=historical&metric_name=eps&utm_content=BCPC&utm_medium=
0 · Reply
Sidoti
Sidoti Apr. 22 at 2:23 PM
New research today on $BCPC #sidotiresearch Read Note: https://buff.ly/VAaSxTZ #investing #smallcap #microcap
0 · Reply
NVDAMillionaire
NVDAMillionaire Mar. 21 at 6:50 AM
$BCPC Digging BCPC's innovative approach in nutrition markets. Strong financials, consistent growth. Potential long-term play in health ingredients sector. Might add to portfolio. valuable article: https://beyondspx.com/article/balchem-corporation-nasdaq-bcpc-delivering-innovation-and-consistent-growth
0 · Reply
swingingtech
swingingtech Mar. 13 at 2:07 PM
$FELC $BRSL $EME $BCPC https://wallstreetwaves.com/surprising-analyst-12-month-target-for-felc/
0 · Reply
Sidoti
Sidoti Feb. 25 at 2:01 PM
New research today on $BCPC #sidotiresearch Read Note: https://buff.ly/3UfmaAX #investing #smallcap #microcap
0 · Reply
d_risk
d_risk Feb. 21 at 10:26 PM
$BCPC - Balchem Corporation Common Stock - 10K - Updated Risk Factors BCPC's 2025 10-K Risk Factors emphasize heightened geopolitical tensions, regulatory scrutiny (e.g., EtO rules), IT reliance, inflation, and restructuring risks, while streamlining or removing specifics on climate, competition, and labor challenges. #Risk https://d-risk.ai/BCPC/10-K/2025-02-21
0 · Reply